Literature DB >> 32149731

One-two punch injury to tolerance mechanisms in graft-versus-host disease.

Léolène J Carrington1,2, Ivan Maillard1,2.   

Abstract

Chronic graft-versus-host disease (GVHD) is a major complication of allogeneic hematopoietic cell transplantation that resembles autoimmunity, with unclear pathogenesis and few effective therapeutic options. In this issue of the JCI, Dertschnig et al. used mouse models to investigate the basis of T cell autoreactivity following GVHD. Notably, GVHD caused irreversible damage to a population of tolerogenic stromal cells that display peripheral tissue-restricted antigens in lymph nodes, which impaired their capacity to purge and suppress autoreactive T cells. Together with damage to central tolerance mechanisms in the thymus, these findings outline a critical one-two punch injury that profoundly disrupts immune tolerance in this devastating disease.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32149731      PMCID: PMC7108886          DOI: 10.1172/JCI136139

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  25 in total

1.  Restoration of lymphoid organ integrity through the interaction of lymphoid tissue-inducer cells with stroma of the T cell zone.

Authors:  Elke Scandella; Beatrice Bolinger; Evelyn Lattmann; Simone Miller; Stéphanie Favre; Dan R Littman; Daniela Finke; Sanjiv A Luther; Tobias Junt; Burkhard Ludewig
Journal:  Nat Immunol       Date:  2008-04-20       Impact factor: 25.606

Review 2.  How I treat refractory chronic graft-versus-host disease.

Authors:  Stefanie Sarantopoulos; Adela R Cardones; Keith M Sullivan
Journal:  Blood       Date:  2019-01-23       Impact factor: 22.113

3.  Loss of lymph node fibroblastic reticular cells and high endothelial cells is associated with humoral immunodeficiency in mouse graft-versus-host disease.

Authors:  Fumiko Suenaga; Satoshi Ueha; Jun Abe; Mizuha Kosugi-Kanaya; Yong Wang; Akihiro Yokoyama; Yusuke Shono; Francis H W Shand; Yasuyuki Morishita; Jun Kunisawa; Shintaro Sato; Hiroshi Kiyono; Kouji Matsushima
Journal:  J Immunol       Date:  2014-11-24       Impact factor: 5.422

4.  The cytolytic molecules Fas ligand and TRAIL are required for murine thymic graft-versus-host disease.

Authors:  Il-Kang Na; Sydney X Lu; Nury L Yim; Gabrielle L Goldberg; Jennifer Tsai; Uttam Rao; Odette M Smith; Christopher G King; David Suh; Daniel Hirschhorn-Cymerman; Lia Palomba; Olaf Penack; Amanda M Holland; Robert R Jenq; Arnab Ghosh; Hien Tran; Taha Merghoub; Chen Liu; Gregory D Sempowski; Melissa Ventevogel; Nicole Beauchemin; Marcel R M van den Brink
Journal:  J Clin Invest       Date:  2009-12-01       Impact factor: 14.808

5.  Thymic damage, impaired negative selection, and development of chronic graft-versus-host disease caused by donor CD4+ and CD8+ T cells.

Authors:  Tao Wu; James S Young; Heather Johnston; Xiong Ni; Ruishu Deng; Jeremy Racine; Miao Wang; Audrey Wang; Ivan Todorov; Jianmin Wang; Defu Zeng
Journal:  J Immunol       Date:  2013-05-24       Impact factor: 5.422

Review 6.  Classification systems for chronic graft-versus-host disease.

Authors:  Stephanie J Lee
Journal:  Blood       Date:  2016-11-07       Impact factor: 22.113

7.  Fibroblastic reticular cells in lymph nodes regulate the homeostasis of naive T cells.

Authors:  Alexander Link; Tobias K Vogt; Stéphanie Favre; Mirjam R Britschgi; Hans Acha-Orbea; Boris Hinz; Jason G Cyster; Sanjiv A Luther
Journal:  Nat Immunol       Date:  2007-09-23       Impact factor: 25.606

8.  Loss of normal thymic repertoire selection and persistence of autoreactive T cells in graft vs host disease.

Authors:  G A Holländer; B Widmer; S J Burakoff
Journal:  J Immunol       Date:  1994-02-15       Impact factor: 5.422

9.  Graft-versus-host disease reduces lymph node display of tissue-restricted self-antigens and promotes autoimmunity.

Authors:  Simone Dertschnig; Pamela Evans; Pedro Santos E Sousa; Teresa Manzo; Ivana R Ferrer; Hans J Stauss; Clare L Bennett; Ronjon Chakraverty
Journal:  J Clin Invest       Date:  2020-04-01       Impact factor: 14.808

10.  Maturation of lymph node fibroblastic reticular cells from myofibroblastic precursors is critical for antiviral immunity.

Authors:  Qian Chai; Lucas Onder; Elke Scandella; Cristina Gil-Cruz; Christian Perez-Shibayama; Jovana Cupovic; Renzo Danuser; Tim Sparwasser; Sanjiv A Luther; Volker Thiel; Thomas Rülicke; Jens V Stein; Thomas Hehlgans; Burkhard Ludewig
Journal:  Immunity       Date:  2013-04-25       Impact factor: 31.745

View more
  1 in total

Review 1.  The long and winding road: homeostatic and disordered haematopoietic microenvironmental niches: a narrative review.

Authors:  Suzanne M Watt
Journal:  Biomater Transl       Date:  2022-03-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.